The CTC-Chip An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients

被引:156
作者
Sequist, Lecia V. [1 ]
Nagrath, Sunitha [2 ]
Toner, Mehmet [2 ]
Haber, Daniel A. [1 ]
Lynch, Thomas J. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, BioMEMS Resource Ctr, Boston, MA USA
关键词
Circulating tumor cells; Non-small cell lung cancer; EGFR mutation; CTC-chip; METASTATIC BREAST-CANCER; ACQUIRED-RESISTANCE; EGFR MUTATIONS; PHASE-II; GEFITINIB; ERLOTINIB; THERAPY;
D O I
10.1097/JTO.0b013e3181989565
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circulating tumor cells (CTCs) are rare cells that originate from a malignancy and circulate freely in the peripheral blood. The ability to capture and study CTCs is an emerging field with implications for early detection, diagnosis, determining prognosis and monitoring of cancer, as well as for understanding the fundamental biology of the process of metastasis, Here, we review the development and initial clinical studies with a novel microfluidic platform for isolating these cells, the CTC-chip, and discuss its potential uses in the study of lung cancer.
引用
收藏
页码:281 / 283
页数:3
相关论文
共 23 条
[21]   First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations [J].
Sequist, Lecia V. ;
Martins, Renato G. ;
Spigel, David ;
Grunberg, Steven M. ;
Spira, Alexander ;
Jaenne, Pasi A. ;
Joshi, Victoria A. ;
McCollum, David ;
Evans, Tracey L. ;
Muzikansky, Alona ;
Kuhlmann, Georgiana L. ;
Han, Moon ;
Goldberg, Jonathan S. ;
Settleman, Jeffrey ;
Iafrate, A. John ;
Engelman, Jeffrey A. ;
Haber, Daniel A. ;
Johnson, Bruce E. ;
Lynch, Thomas J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2442-2449
[22]   EGFR tyrosine kinase inhibitors in lung cancer: An evolving story [J].
Sequist, Lecia V. ;
Lynch, Thomas J. .
ANNUAL REVIEW OF MEDICINE, 2008, 59 :429-442
[23]  
Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585